Dividend stocks continue to grab the headlines in the stock market today. Seeing that major indices performed poorly during the first half of the year,… Read More »What Stocks To Buy Today? 5 Dividend Stocks To Watch In This Bear Market
Do you just want to set it and forget it, so to speak? While this mindset is the essence of a buy-and-hold strategy, it also… Read More »3 Unstoppable Investments Everyone Needs In Their Portfolio
With interest rates expected to continue to rise through the end of the year, many investors are worried about the potential impact on their investments.… Read More »This Fixed Income ETF Is Poised To Outperform Equities During Rising Rates
The best companies to invest in might be those that are making significant investments in themselves. So says the While, at first glance, software stocks… Read More »A Sales Screen For Software Stocks
The best companies to invest in might be those that are making significant investments in themselves. So says the chief US equity strategist at Goldman… Read More »Invest In These Stocks That Are Investing More In Themselves
It’s not too late to get in on the best-performing sector of 2021 – energy. Here are Wall Street’s favorite energy stocks with the highest… Read More »Wall Street’s Favorite Stocks From 2021’s Best-Performing Sector
With robust growth potential, these seven “cult” stocks are positioned to be the next Tesla in terms of generating outstanding returns for shareholders. CLICK HERE.
With average analyst price targets that are significantly higher than where they have been recently trading, these two dozen stocks are among the most undervalued… Read More »When It Comes To Being Undervalued, These 24 Stocks Are Tops
Biotech stocks are all the rage right now – and within the biotech sector, deals are all the rage. Here’s a look at recent investments,… Read More »Biotech Wheeling And Dealing
With the first FDA-approved drug for weight management in people with rare genetic disorders of obesity – its first new drug approval – shares of… Read More »FDA Approval Of Its Obesity Drug Has This Small Biotech Rocketing Up